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INTRODUCTION
Mycoplasma pneumoniae is	 a	 common	 etiological	
agent	of	respiratory	tract	infections	in	humans,	mainly	
primary-school	 children.	 Epidemic	 outbreaks	 of	M. 
pneumoniae	 occur	 usually	 at	 4	 to	 7	 years	 intervals.	
The	P1	transmembrane	protein	of	M. pneumoniae me-
diates	the	attachment	of	the	pathogen	to	the	host	cells	
and	elicits	a	strong	humoral	immune	response	during	
infection	 in	 patients1,2,3.	 P1	 cytadhesin	 is	 a	 169-kDa	
protein	encoded	by	a	gene	of	approx.	5,000	bp,	which	
contains	a	copy	of	each	repetitive	regions	DNA	ele-
ments	RepMP2/3	and	RepMP44.	Su	et	al.,5	first	clas-
sified	M. pneumoniae	strains	into	two	groups	on	the	
basis	of	differences	in	the	P1	gene,	and	speculated	that	
sequence	divergence	of	the	two	groups	may	influence	
the	tropism	and	virulence	of	the	strains	prompting	for	
further	comparative	studies.	Analysis	of	P1	genes	of	
M. pneumoniae isolates	by	Southern	blotting6,	DNA	
fingerprinting7,	and	restriction	fragment	length	poly-
morphism	(RFLP)8	techniques	revealed	also	two	types.	
On	the	basis	of	variation	within	the	P1	gene,	Dorigo-
Zetsma	et	al.9	found	eight	subtypes	in	the	two	groups,	
while	Cousin-Allery	et	al.10	using	RFLP,	RAPD	and	
PFGE	found	two	closely	related	subgroups	into	group	
2.	Recombinant	strains	have	been	reported	arising	by	
exchanging	segments	of	different	genes11,12.	Recently	
Dumke	et	al.13	using	extended	genome	sequencing	and	
expression	profiles	concluded	that	M. pneumoniae	is	
a	highly	uniform	species	with	P1	being	the	major	tar-
get	for	epidemiological	screening	and	that	most	of	the	
isolates	could	be	assigned	to	one	of	the	two	groups	1	
and	2.	So	far,	no	relation	between	types	and	severity	
of	the	disease	has	been	reported.	
In	Greece,	M. pneumoniae	 accounts	 for	approxi-
mately	11%14	of	atypical	pneumonia	cases	in	children.	
Laboratory	 diagnosis	 is	 based	 mainly	 on	 serology,	
while	 culture	 of	 these	 fastidiously	 growing	 bacteria	
is	usually	not	applied;	for	 this	reason	no	stocked	M. 
pneumoniae	strains	from	former	years	were	available.	
A	 study	 on	 comparison	 among	 different	 diagnostic	
methods	(culture,	EIA-antigen	detection,	PCR,	ELISA	
and	western-blot	 for	 detection	 of	 specific	 IgG,	 IgM	
and	 IgA	antibodies	 against	M. pneumoniae)	 showed	
that	the	combination	of	PCR	and	IgM-capture	ELISA	
is	highly	sensitive	for	rapid	diagnosis	of	acute	phase	
M. pneumonia	infection	in	children14.	Aim	of	the	pres-
ent	study	was	to	type	M. pneumoniae	strains	using	as	
starting	material	 throat	 swab	 specimens	 from	hospi-
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talized	 children	 with	 respiratory	 tract	 infection	 and	
to	 gain	 information	 on	 the	 types	 of	M. pneumoniae	
strains	circulating	in	Greece	in	2003.	
MATeRIAlS AND MeThODS
During	May	 2003	 to	April	 2004	 throat	 swab	 speci-
mens	were	obtained	 from	210	children	 (94	 female	 -	
116	male)	with	mean	age	4.4	years	(range	2	months	to	
14	years)	who	were	hospitalized	due	to	acute	respira-
tory	tract	infection	in	Thessaloniki,	Northern	Greece.	
Initially	a	diagnostic	PCR	was	performed,	which	
amplifies	 a	 209-bp	 region	 of	 the	 P1	 adhesin	 gene15.	
On	randomly	selected	PCR-positive	samples	a	 type-
specific	 PCR	 was	 applied	 using	 primers	 P1-40	 and	
MPAW1,	which	amplify	a	1110-bp	region	of	the	P1	ad-
hesin	gene16.	DNA	was	extracted	directly	from	throat	
swab	specimens	using	the	Qiagen	DNA	extraction	kit	
(Qiagen	GmbH	Hilden,	Germany).	Sequencing	of	the	
PCR	 products	 was	 performed	 using	 the	 ThermoSe-
quenase	Cy5.5	Dye	Terminator	Cycle	Sequencing	kit	
(Amersham	Biosciences	UK	Limited)	in	an	OpenGe-
neTM	System	(Visisble	Genetics,	Toronto,	Ca).
ReSUlTS
Twenty-four	 of	 210	 specimens	 (11.4%)	 were	 found	
positive	using	the	diagnostic	PCR.	In	fourteen	of	the	
positive	 specimens	 the	 type-specific	 PCR	 was	 ap-
plied;	in	seven	of	them	an	amplicon	of	1110	bp	was	
obtained	and	sequenced.	BLAST	analysis	shown	that	
six	 sequences	 presented	 100%	 similarity	 with	 P1	
type	 1	 reference	 strain	M129	 (ATCC	29342),	while	
one	was	identical	to	P1	type	2	reference	strain	MAC	
(ATCC	 15492).	 Epidemiological	 characteristics	 and	
clinical	signs	and	symptoms	were	similar	among	all	
seven	patients	(Table	1).	
DISCUSSION
In	the	present	study	it	was	found	that	M. pneumoniae 
DNA	was	detected	in	11.4%	of	hospitalized	children	
with	acute	respiratory	tract	infection.	Both	diagnostic	
and	typing	PCRs	were	performed	with	DNA	extracted	
directly	from	throat	swab	specimens	from	the	patients.	
Positive	results	from	the	typing	PCR	were	taken	from	
half	(7/14)	of	the	samples	which	were	positive	in	the	
diagnostic	 PCR.	The	 lower	 success	 rate	was	 due	 to	
the	fact	that	the	size	of	the	typing	PCR	product	was	
much	higher	than	that	of	the	diagnostic	PCR	(1110	bp	
versus	209	bp).	It	was	found	that	the	majority	of	the	
M. pneumoniae	strains	belonged	to	type	1.
On	the	basis	of	genotyping	most	of	M. pneumoni-
ae	strains	can	be	divided	into	two	major	types,	1	and	
2.	M. pneumoniae type	predominance	differs	among	
countries,	 and	 even	 among	year	 of	 isolation,	 and	 in	
addition,	 a	 shift	 from	one	 subtype	 to	 another	 is	 ob-
served	 unevenly.	 For	 example,	 retrospective	 studies	
on	 strains	 isolated	 in	 France	 and	 Denmark	 showed	
that	most	of	the	Danish	strains	of	1962-86	belonged	to	
type	1,	almost	all	Danish	and	French	strains	of	1987-
88	belonged	to	type	2,	while	during	1991-93	almost	
all	 strains	 (including	German	and	Belgian	ones)	be-
longed	 to	 type	 1	 (10).	 Predominant	M. pneumoniae 
type	in	Germany	during	the	time	period	1989	to	1996	
was	type	1	and	in	1997-98	was	type	2,	while	the	vari-
ant	DR	was	detected	only	in	1991	and	199517.	In	Ja-
pan,	predominance	of	type	2	was	observed	in	strains	
isolated	in	1979-80	and	in	1994-95,	while	the	period	in	
Table 1.	Epidemiological	and	clinical	data	of	the	patients.
No Date	of	specimen	
collection
Age
(y) Gender Disease
Fever	
(oC)
WBC	
X109/L
M. pneumoniae		
type
	7 June	2003 12	 Female pneumonia 39.0 5,700 Type	1
48 June	2003 8.5	 Male pneumonia 39.5 14,800 Type	1
34 July	2003 10	 Male pneumonia 39.3 12,500 Type	1
51 August	2003 2.5	 Male pneumonia 38.3 14,400 Type	2
56 September	2003 6.5	 Female pneumonia 39.4 10,100 Type	1
64 September	2003 3	 Female pharyngitis 40.5 13,300 Type	1
83 October	2003 9	 Male pneumonia 40 7,600 Type	1
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between	(1985-1991)	there	was	predominance	of	type	
18.	In	Australia	type	2	was	more	commonly	implicated	
in	pneumonia	cases	among	children	in	1998-9916.	It	is	
obvious	that	the	distribution	of	M. pneumoniae strains	
is	not	homogenous	in	different	regions	of	the	world,	
and	it	was	suggested	that	immunoresponse	to	epitopes	
that	differ	in	the	two	groups	of	P1	proteins	influence	
the	relative	dominance	of	one	or	the	other	type8.	Ex-
periments	in	an	animal	model	showed	that	pre-infec-
tion	of	the	host	with	M. pneumoniae	strains	of	a	cer-
tain	type	causes	a	type-specific	immunity	with	strong	
influence	on	the	type	of	the	surviving	bacteria13.
Although	strains	from	other	years	were	not	avail-
able,	 the	present	study	provided	preliminary	data	on	
the	types	of	M. pneumoniae	strains	in	Greece,	where	
it	can	be	assumed	that	M. pneumoniae	type	1	was	pre-
dominant	in	2003.	Future	studies	on	strains	collected	
in	different	countries	and	time	periods	will	give	a	bet-
ter	 insight	 into	molecular	epidemiology	of	M. pneu-
moniae,	and	will	help	to	find	out	any	probable	relation	
between	 types	 and	 pathogenicity	 to	 humans,	 and	 to	
define	the	factors	implicating	in	type	shifts.
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ΠΕΡΙΛΗΨΗ:	Κατά	τη	διάρκεια	του	2003	συλλέχθηκαν	φαρυγγικά	επιχρίσματα	από	παιδιά	που	νοσηλεύτηκαν	με	οξεία	
λοίμωξη	αναπνευστικού	συστήματος.	Σκοπός	της	μελέτης	ήταν	να	ανιχνευτεί	και	να	τυποποιηθεί	το	Μυκόπλασμα	της	πνευ-
μονίας	κατ’	ευθείαν	από	το	κλινικό	δείγμα,	χωρίς	καλλιέργεια	του	βακτηρίου.	Για	την	τυποποίηση	του	Μ.	της	πνευμονίας	
εφαρμόστηκε	μία	PCR	που	ενισχύει	μία	περιοχή	του	γονιδίου	P1,	το	οποίο	ευθύνεται	για	την	προσκόλληση	των	βακτηρίων	
στα	κύτταρα	του	ξενιστή.	Ακολούθησε	αλληλούχιση	νουκλεοτιδίων	και	μελετήθηκαν	οι	γενετικές	διαφορές	μεταξύ	των	
στελεχών.	Μυκόπλασμα	της	πνευμονίας	ανιχνεύτηκε	σε	ποσοστό	11,4%	των	δειγμάτων,	με	επικρατέστερο	των	τύπο	1.
Λέξεις Κλειδιά: Μυκόπλασμα πνευμονίας, Πνευμονία, Ελλάδα, Γονότυποι, Μοριακή επιδημιολογία.
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